Getting overwhelmed by the news is an everyday struggle for those wishing to stay in touch with the latest news. Our newsletter should make it easier for those interested in pharmacovigilance regulations, advancement in the relevant use of artificial intelligence, and personal growth. Approaching with care, the same as we provide PV services, we thoughtfully pick articles every month to keep you updated.
Seven emerging AI healthcare technologies have been selected for the second phase of the MHRA’s AI Airlock programme.
The agency will no longer require studies comparing copycat biologics to their branded counterparts, which could help developers bring them to market more quickly and cheaply.
In six months’ time, on 28 April 2026, the most significant update to UK clinical trials regulations in two decades will come into force.
And much more...

In six months’ time, on 28 April 2026, the most significant update to UK clinical trials regulations in two decades will come into force.

Advice on end-of-year submission dates for type I variations in 2025

How to create, submit and manage IRIS applications, for industry and individual applicants

Seven emerging AI healthcare technologies have been selected for the second phase of the MHRA’s AI Airlock programme.

What do you get when you fall in love with AI in healthcare? A guy with a pin to burst your bubble.

Create a document, several pages long, that explains who you are. What sort of learner are you? Do you have degrees or expertise? What sort of change are you making, who works with you, what are your standards? How do you want to engage?

The agency will no longer require studies comparing copycat biologics to their branded counterparts, which could help developers bring them to market more quickly and cheaply.

When people regularly ask for input, it sets a powerful norm: learning is valued more than perfection.

A new study from researchers at The University of Texas MD Anderson Cancer Center shows that the glucose-fructose mix found in sugary drinks directly fuels metastasis in preclinical models of advanced colorectal cancer.
Pictures used in this newsletter were generated by AI.